eluSCIdate

Meggen, Switzerland Founded: 2020 • Age: 6 yrs Acquired By Cactus Life Sciences
Medical writing, editorial support, and scientific planning services are offered.

About eluSCIdate

eluSCIdate is a company based in Meggen (Switzerland) founded in 2020 was acquired by Cactus Life Sciences in April 2024. eluSCIdate offers products and services including Medical Communications. eluSCIdate operates in a competitive market with competitors including Soterius, SFL Regulatory Affairs & Scientific Communication, InfocusRx, Triadelta Partners and Scinopsis, among others.

Key Metrics

Products & Services of eluSCIdate

eluSCIdate offers a comprehensive portfolio of products and services, including Medical Communications.

Medical Communications
Healthcare Services

Facilitates scientific exchange to bridge data and real-world impact in biopharmaceuticals.

Investors in eluSCIdate

eluSCIdate has secured backing from 1 investor. Prominent investors backing the company include Cactus Life Sciences.

All
InvestorDescriptionFounded YearDomainLocation
Offers medical communications, scientific strategies, patient engagement, and global biopharma services.
2010cactuslifesciences.comPrinceton, United States
Premium access

Investor details for eluSCIdate

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of eluSCIdate

2 dated milestones of eluSCIdate across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded eluSCIdate is founded.
  2. Exit Acquired by Cactus Life Sciences.

Competitors of eluSCIdate

eluSCIdate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Soterius, SFL Regulatory Affairs & Scientific Communication, InfocusRx, Triadelta Partners and Scinopsis, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
soterius.com2018Princeton, United States$1.5M38
Pharmacovigilance, medical affairs, and drug safety services are provided.
sfl-services.com2009Basel, Switzerland––
Consulting services in regulatory affairs and scientific communication are provided.
infocusrx.com2008Hyderabad, India–9
Offers branding, digital marketing, and knowledge services for healthcare industries.
triadeltapartners.com2014Zagreb, Croatia––
Medical writing services are provided to healthcare clients.
scinopsis.com2006Frejus, France––
Semiconductor and power electronic devices are manufactured for various sectors.
regprofessional.com1995Newark, United States––
Regulatory consulting services for medical writing and strategies are provided.
axpharma.com2001Paris, France––
Provider of vigilance, case treatment, and medical writing services for life science companies
sclintech.com2015Secunderabad, India––
Delivers clinical trial data management and medical writing services for the biopharma industry.
Premium access

Detailed competitors of eluSCIdate

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Eluscidate

Premium access

Complete news archive for eluSCIdate

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to eluSCIdate

10 companies that operate in the same segment as eluSCIdate (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about eluSCIdate

eluSCIdate was founded in 2020.

eluSCIdate is headquartered in Meggen, Switzerland. It is registered at Meggen, Luzern, Switzerland.

eluSCIdate was established in 2020 in Meggen, Switzerland. Services in medical writing, editorial support, and scientific planning are provided to support clients in the healthcare and scientific sectors. Operations focus on delivering specialized assistance for documentation, content development, and strategic planning in medical contexts. The company operates primarily from its Swiss base, serving international needs in the life sciences industry.

eluSCIdate offers Medical Communications.

eluSCIdate has 1 investor. Key investors include Cactus Life Sciences.

Yes. eluSCIdate was acquired by Cactus Life Sciences in April 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available